Biotech RadarJobs updated

COMPANY

Aurion Biotech

HQ: Seattle, WA source · aurionbiotech.com ↗ · West Coast

Status: Acquired, now part of Alcon · How status works

Clinical Phase 3

7 open jobs · last seen Oct 23, 2026 · 4 sources

Keywords: blindness cell therapy ophthalmology Corneal Edema Corneal Endothelial Dysfunction Fuchs Endothelial Corneal Dysfunction Pseudophakic Bullous Keratopathy AURN001 Y27632 Cryopreserved AURN001 HCEC-1

Location: Seattle, WA · source · Jan 24, 2025

Profile checked Oct 10, 2026

7Open jobs4Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Principal Engineer, MSATRemote - WA or MA Preferred - WA, NM, SD, TX, IN, SC, NC, PA, NY, NH, KY, WI, MS, MA applicants onlyOct 16, 2026Oct 17, 2026
Senior Scientist, Analytical Science & TechnologyUS Remote - WA, MA, NC, NJ, NH, NM, NY, PA, SC, SD, TX, IN, WI, MS or KY applicants onlyOct 12, 2026Oct 16, 2026
Associate Director, Manufacturing Business Operations & StrategyUS Remote - WA, MA, NC, NJ, NH, NM, NY, PA, SC, SD, TX, IN, or KY applicants onlyOct 1, 2026Oct 16, 2026
Senior Quality AssociateUS Remote - WA, MA, NC, NJ, NH, NM, NY, PA, SC, SD, TX, KY, MS, IN applicants onlySep 9, 2026Oct 16, 2026
Associate Director, Quality AssuranceUS Remote - WA, MA, NC, NJ, NH, NM, NY, PA, SC, SD, TX, KY, MS, IN applicants onlySep 9, 2026Oct 16, 2026

See all 7 jobs

Timeline

  1. Trial start Phase 3: AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction source ↗
  2. Trial start Phase 2: Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction source ↗
  3. Trial start 1: A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1) source ↗
  4. Trial start Phase 1: A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 4

RecordTitlePhaseStatusStartPrimary completion
NCT07368959AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial DysfunctionPhase 3Active, not recruitingFeb 19, 20262027-06 (estimated)
NCT06041256A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)1CompletedOct 18, 2023Oct 25, 2024 (actual)
NCT06630169Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial DysfunctionPhase 2Active, not recruitingSep 16, 20242025-10 (estimated)
NCT05309135A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial DysfunctionPhase 1CompletedMar 24, 2022Mar 9, 2023 (actual)

Open jobs 7

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Principal Engineer, MSATRemote - WA or MA Preferred - WA, NM, SD, TX, IN, SC, NC, PA, NY, NH, KY, WI, MS, MA applicants onlyOct 16, 2026Oct 17, 2026Not stated
Senior Scientist, Analytical Science & TechnologyUS Remote - WA, MA, NC, NJ, NH, NM, NY, PA, SC, SD, TX, IN, WI, MS or KY applicants onlyOct 12, 2026Oct 16, 2026Not stated
Associate Director, Manufacturing Business Operations & StrategyUS Remote - WA, MA, NC, NJ, NH, NM, NY, PA, SC, SD, TX, IN, or KY applicants onlyOct 1, 2026Oct 16, 2026Not stated
Senior Quality AssociateUS Remote - WA, MA, NC, NJ, NH, NM, NY, PA, SC, SD, TX, KY, MS, IN applicants onlySep 9, 2026Oct 16, 2026Not stated
Associate Director, Quality AssuranceUS Remote - WA, MA, NC, NJ, NH, NM, NY, PA, SC, SD, TX, KY, MS, IN applicants onlySep 9, 2026Oct 16, 2026Not stated
Human Resources Operations ManagerSeattle, WA (Hybrid), RemoteSep 2, 2026Oct 16, 2026Not stated
Senior Engineer, MSATUS Remote - WA, MA, NC, NJ, NH, NM, NY, PA, SC, SD, TX, KY, MS or IN applicants onlyAug 21, 2026Oct 16, 2026Not stated

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Connect

See your connections at Aurion Biotech on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18

Feedback